SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000830656-02-000019
Filing Date
2002-08-13
Accepted
2002-08-13 17:12:55
Documents
12
Period of Report
2002-06-30

Document Format Files

Seq Description Document Type Size
1 FOR THE THREE AND SIX MONTHS ENDED 6/30/02 form10-q2_2002.htm 10-Q 68695
3 GRAPHIC balance_sheets.gif GRAPHIC 17550
4 GRAPHIC cash_flow.gif GRAPHIC 21613
5 GRAPHIC eps.gif GRAPHIC 8065
6 GRAPHIC exhibit_listing.gif GRAPHIC 72189
7 GRAPHIC income_statement.gif GRAPHIC 18680
8 GRAPHIC inventories.gif GRAPHIC 3577
9 GRAPHIC logo.gif GRAPHIC 2834
10 GRAPHIC segment_assets.gif GRAPHIC 4542
11 GRAPHIC segment_operatingloss.gif GRAPHIC 5913
12 GRAPHIC segment_revenue.gif GRAPHIC 5841
13 sarbanes-oxley_cert.htm EX-99 6360
  Complete submission text file 0000830656-02-000019.txt   238595
Mailing Address 375 WEST ST WEST BRIDGEWATER MA 02379
Business Address 375 WEST STREET WEST BRIDGEWATER MA 02379 5085801900
BOSTON BIOMEDICA INC (Filer) CIK: 0000830656 (see all company filings)

IRS No.: 042652826 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21615 | Film No.: 02730638
SIC: 2835 In Vitro & In Vivo Diagnostic Substances